In the last trading session, 1.45 million shares of the Amarin Corp ADR (NASDAQ:AMRN) were traded, and its beta was 1.41. Most recently the company’s share price was $0.46, and it changed around $0.02 or 4.96% from the last close, which brings the market valuation of the company to $188.13M. AMRN currently trades at a discount to its 52-week high of $1.11, offering almost -141.3% off that amount. The share price’s 52-week low was $0.35, which indicates that the current value has risen by an impressive 23.91% since then. We note from Amarin Corp ADR’s average daily trading volume that its 10-day average is 3.52 million shares, with the 3-month average coming to 1.59 million.
Amarin Corp ADR stock received a consensus recommendation rating of Underweight, based on a mean score of 4.33. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended AMRN as a Hold, whereas 0 deemed it a Buy, and 2 rated it as Underweight. Amarin Corp ADR is expected to report earnings per share of -0.02 for the current quarter.
Amarin Corp ADR (NASDAQ:AMRN) trade information
Instantly AMRN has showed a green trend with a performance of 4.96% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.4970 on recent trading dayincreased the stock’s daily price by 7.44%. The company’s shares are currently down -5.75% year-to-date, but still up 10.46% over the last five days. On the other hand, Amarin Corp ADR (NASDAQ:AMRN) is -23.05% down in the 30-day period. We can see from the shorts that 16.79 million shares have been sold at a short interest cover period of 18.83 day(s).
The consensus price target as assigned by Wall Street analysts is $2, which translates to bulls needing to increase their stock price by 77.0% from its current value. Analyst projections state that AMRN is forecast to be at a low of $1.5 and a high of $3.
Amarin Corp ADR (AMRN) estimates and forecasts
The year-over-year growth rate is expected to be -19.13%, down from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 50.28M in revenue for the current quarter. 2 analysts expect Amarin Corp ADR to make 48.11M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 56.52M and 67.49M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -11.04%. Forecasts for the next quarter put sales growth at -28.71%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -24.69%. Amarin Corp ADR earnings are expected to increase by 12.20% in 2025, but the outlook is positive 27.89% per year for the next five years.
AMRN Dividends
Amarin Corp ADR’s next quarterly earnings report is expected to be released on 2025-Mar-11.
Amarin Corp ADR (NASDAQ:AMRN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.63% of Amarin Corp ADR shares, and 18.11% of them are in the hands of institutional investors. The stock currently has a share float of 18.41%. Amarin Corp ADR stock is held by 193.0 institutions, with SARISSA CAPITAL MANAGEMENT LP being the largest institutional investor. By 2024-06-30, it held 6.0486% of the shares, which is about 24.85 million shares worth $17.1 million.
KYNAM CAPITAL MANAGEMENT, LP, with 2.9587% or 12.16 million shares worth $8.36 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
SPDR(R) Portfolio Developed World ex-US ETF and Macquarie Healthcare Fund were the top two Mutual Funds as of Jan 31, 2025 . The former held 267.29 shares worth $0.12 million, making up 0.27% of all outstanding shares. On the other hand, Macquarie Healthcare Fund held roughly 190.0 shares worth around $86849.0, which represents about 0.19% of the total shares outstanding.
